Physician Workforce Diversity Trends, Barriers, and Solutions
Produktdetaljer
Om bidragsyterne
Dr. Curtiland Deville is an Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine.
He is a graduate of Brown University’s combined undergraduate and graduate Program in Liberal Medical Education (PLME) and a past Doris Duke Clinical Research Fellow at the Yale Cancer Center. He completed his transitional year internship in internal medicine at Medstar Harbor Hospital Center in Baltimore, Maryland, and residency in radiation oncology at the Hospital of the University of Pennsylvania, where he joined the junior faculty as an Assistant Professor and served as clinical Chief of the Genitourinary (GU) and Sarcoma Services in the Department of Radiation Oncology and Roberts Proton Therapy Center. He serves as Medical Director of the Johns Hopkins Proton Therapy Center and Clinical Director of the Department of Radiation Oncology at Sibley Memorial Hospital, Johns Hopkins Medicine. Dr. Deville’s clinical expertise involves treating patients with prostate cancer and soft tissue sarcoma. His funded clinical research interests include improving tumor targeting and assessing the toxicity profiles using modern radiation techniques such as proton and photon therapy. He has evaluated the implementation of proton therapy for novel indications such as whole pelvis and post-prostatectomy therapy, pencil beam scanning, and robustness evaluations. He has co-authored over 170 peer-reviewed publications, including the first experience and outcomes in the world on the use of proton therapy for post-operative prostate cancer. He serves as Deputy Editor for the International Journal of Radiation Oncology, Biology, Physics.
Dr. Deville also has a research interest in physician workforce diversity as a means to addressing health equity, particularly in specialties with disparities in the representation of women, individuals from racial and ethnic minority groups that are historically underrepresented in medicine (UIM), and other marginalized demographic identities. He is a leading voice in health equity, diversity, and inclusion in Radiation Oncology since co-authoring the first publication in the field dedicated to workforce diversity over a decade ago. He is a past Chair of the American Society for Radiation Oncology’s (ASTRO) Committee on Health Equity, Diversity and Inclusion and a past Chair of the American Society for Clinical Oncology’s (ASCO) Diversity in Oncology Subcommittee, managing both of their pathway programs for UIM students and trainees. He was recently elected to the ASTRO Board of Directors and spearheaded the formation of the Council on Health Equity, Diversity & Inclusion.
Produktdetaljer
Om bidragsyterne
Dr. Curtiland Deville is an Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine.
He is a graduate of Brown University’s combined undergraduate and graduate Program in Liberal Medical Education (PLME) and a past Doris Duke Clinical Research Fellow at the Yale Cancer Center. He completed his transitional year internship in internal medicine at Medstar Harbor Hospital Center in Baltimore, Maryland, and residency in radiation oncology at the Hospital of the University of Pennsylvania, where he joined the junior faculty as an Assistant Professor and served as clinical Chief of the Genitourinary (GU) and Sarcoma Services in the Department of Radiation Oncology and Roberts Proton Therapy Center. He serves as Medical Director of the Johns Hopkins Proton Therapy Center and Clinical Director of the Department of Radiation Oncology at Sibley Memorial Hospital, Johns Hopkins Medicine. Dr. Deville’s clinical expertise involves treating patients with prostate cancer and soft tissue sarcoma. His funded clinical research interests include improving tumor targeting and assessing the toxicity profiles using modern radiation techniques such as proton and photon therapy. He has evaluated the implementation of proton therapy for novel indications such as whole pelvis and post-prostatectomy therapy, pencil beam scanning, and robustness evaluations. He has co-authored over 170 peer-reviewed publications, including the first experience and outcomes in the world on the use of proton therapy for post-operative prostate cancer. He serves as Deputy Editor for the International Journal of Radiation Oncology, Biology, Physics.
Dr. Deville also has a research interest in physician workforce diversity as a means to addressing health equity, particularly in specialties with disparities in the representation of women, individuals from racial and ethnic minority groups that are historically underrepresented in medicine (UIM), and other marginalized demographic identities. He is a leading voice in health equity, diversity, and inclusion in Radiation Oncology since co-authoring the first publication in the field dedicated to workforce diversity over a decade ago. He is a past Chair of the American Society for Radiation Oncology’s (ASTRO) Committee on Health Equity, Diversity and Inclusion and a past Chair of the American Society for Clinical Oncology’s (ASCO) Diversity in Oncology Subcommittee, managing both of their pathway programs for UIM students and trainees. He was recently elected to the ASTRO Board of Directors and spearheaded the formation of the Council on Health Equity, Diversity & Inclusion.